Lemborexant Use for Cognition Improvement in Postoperative Delirium in Elderly Patients: A Randomized Controlled Trial
Conditions : Postoperative Delirium Interventions : Drug: Lemborexant Pill; Drug: Placebo tablet Sponsors : Beijing Tiantan Hospital Not yet recruiting
Read the full articleYou might also wanna read
Study finds placebo pills improve memory and physical performance in older adults, even when they know they're fake
Older adults who knowingly took placebo pills showed significant gains in memory, physical performance, and stress reduction, highlighting t
They knew the pill was fake but their memory still improved
Healthy older adults experienced measurable improvements in memory, physical performance, and stress after taking placebo pills for just thr
Severe Alzheimer's patient shows improved cognition and speech after psilocybin dose
A woman with severe Alzheimer's disease who hadn't spoken more than monosyllables in years began initiating conversation after a single dose
newscientist.com·13d agoSevere Alzheimer's patient shows improved cognition and speech after psilocybin dose
A woman with severe Alzheimer's disease who hadn't spoken more than monosyllables in years began initiating conversation after a single dose
newscientist.com·13d ago
Transient functional improvements in advanced Alzheimer's disease following high-dose psilocybin: a case report
BackgroundAdvanced Alzheimer’s disease (AD) is generally regarded as a stage of irreversible functional decline. Psilocybin is known to tran
frontiersin.org·25d ago
Exploring the Role of NMDA Receptor Antagonists in Anesthesia, Alzheimer's, and Depression
Insights from Memantine and Ketamine's divergent effects on the Brain
grillbert.substack.com·11mo ago
Neurologists reassess dopamine agonists as first-line Parkinson's treatment amid impulse control concerns
New discussion around Parkinson’s treatment is putting dopamine agonists under the spotlight, with clinicians balancing motor benefits again
mdsc.pe·2d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.